Vir Biotechnology VIR
NASDAQ VIR
$10.57 +0.14 (+1.34%)
At close: Oct 23, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Sale and Maturity of Investments (2018 - 2026)

Updated

Analysis

Vir Biotechnology (VIR) Sale and Maturity of Investments (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Vir Biotechnology 1.79 Bn -169.51 Mn 238.95 Mn 154.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 154.99 Mn
Mar 31, 2026 170.60 Mn
Dec 31, 2025 342.93 Mn
Sep 30, 2025 305.17 Mn
Jun 30, 2025 251.32 Mn
Mar 31, 2025 301.86 Mn
Dec 31, 2024 301.14 Mn
Sep 30, 2024 361.51 Mn
Jun 30, 2024 483.29 Mn
Mar 31, 2024 592.70 Mn
Dec 31, 2023 715.71 Mn
Sep 30, 2023 447.67 Mn
Jun 30, 2023 549.55 Mn
Mar 31, 2023 489.46 Mn
Dec 31, 2022 266.67 Mn
Sep 30, 2022 84.84 Mn
Sep 30, 2021 79.86 Mn
Jun 30, 2021 128.18 Mn
Mar 31, 2021 93.20 Mn
Dec 31, 2020 103.59 Mn
API Access

Vir Biotechnology Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=VIR&period=max&api_key=YOUR_API_KEY